Molina Healthcare, Inc. (NYSE:MOH) Shares Sold by Russell Investments Group Ltd.

Russell Investments Group Ltd. lowered its stake in Molina Healthcare, Inc. (NYSE:MOH) by 51.5% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 70,973 shares of the company’s stock after selling 75,255 shares during the quarter. Russell Investments Group Ltd.’s holdings in Molina Healthcare were worth $21,317,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of MOH. DekaBank Deutsche Girozentrale lifted its holdings in Molina Healthcare by 1.1% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 95,967 shares of the company’s stock valued at $28,134,000 after acquiring an additional 1,087 shares during the last quarter. Westpac Banking Corp lifted its holdings in Molina Healthcare by 520.8% in the 1st quarter. Westpac Banking Corp now owns 28,348 shares of the company’s stock valued at $7,583,000 after acquiring an additional 23,782 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its holdings in Molina Healthcare by 1.1% in the 1st quarter. Oregon Public Employees Retirement Fund now owns 11,686 shares of the company’s stock valued at $3,126,000 after acquiring an additional 128 shares during the last quarter. Tredje AP fonden lifted its holdings in Molina Healthcare by 5.4% in the 1st quarter. Tredje AP fonden now owns 12,383 shares of the company’s stock valued at $3,312,000 after acquiring an additional 637 shares during the last quarter. Finally, New Mexico Educational Retirement Board lifted its holdings in Molina Healthcare by 3.7% in the 2nd quarter. New Mexico Educational Retirement Board now owns 2,800 shares of the company’s stock valued at $843,000 after acquiring an additional 100 shares during the last quarter. Institutional investors and hedge funds own 98.11% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on MOH shares. Cantor Fitzgerald reissued an “overweight” rating and issued a $359.00 price target on shares of Molina Healthcare in a report on Thursday, September 14th. JPMorgan Chase & Co. boosted their price objective on Molina Healthcare from $367.00 to $392.00 and gave the stock an “overweight” rating in a report on Friday. StockNews.com upgraded Molina Healthcare from a “buy” rating to a “strong-buy” rating in a report on Thursday, October 12th. Bank of America boosted their price objective on Molina Healthcare from $340.00 to $350.00 in a report on Thursday, July 27th. Finally, Stephens restated an “equal weight” rating and set a $350.00 price objective on shares of Molina Healthcare in a report on Tuesday, October 3rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $348.45.

Molina Healthcare Price Performance

Shares of MOH opened at $356.28 on Tuesday. The company has a market capitalization of $20.77 billion, a price-to-earnings ratio of 22.21, a P/E/G ratio of 1.21 and a beta of 0.57. Molina Healthcare, Inc. has a fifty-two week low of $256.19 and a fifty-two week high of $369.50. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.47 and a quick ratio of 1.47. The business’s 50-day moving average is $340.05 and its 200-day moving average is $313.54.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, October 25th. The company reported $5.05 earnings per share for the quarter, beating analysts’ consensus estimates of $4.87 by $0.18. The company had revenue of $8.55 billion for the quarter, compared to the consensus estimate of $8.24 billion. Molina Healthcare had a return on equity of 34.85% and a net margin of 2.80%. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $4.36 EPS. Equities research analysts expect that Molina Healthcare, Inc. will post 20.83 EPS for the current fiscal year.

Insider Activity

In related news, Director Steven J. Orlando sold 1,134 shares of the stock in a transaction that occurred on Monday, October 30th. The stock was sold at an average price of $325.96, for a total value of $369,638.64. Following the transaction, the director now owns 19,299 shares in the company, valued at $6,290,702.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, CAO Maurice Hebert sold 692 shares of the stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $328.15, for a total value of $227,079.80. Following the transaction, the chief accounting officer now owns 8,528 shares in the company, valued at $2,798,463.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Steven J. Orlando sold 1,134 shares of the stock in a transaction that occurred on Monday, October 30th. The stock was sold at an average price of $325.96, for a total value of $369,638.64. Following the completion of the transaction, the director now owns 19,299 shares in the company, valued at approximately $6,290,702.04. The disclosure for this sale can be found here. 1.10% of the stock is owned by corporate insiders.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.